Inhibitory effects of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives on vascular smooth muscle cell mitogenesis and proliferation in vitro

British Journal of Pharmacology

Volumn 125, Issue 2, 1998, Pages 402-408

  Lähteenmäki, Tuula ^a   Sievi, Eeva ^a   Vapaatalo, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cyclic GMP; DNA synthesis; Mesoionic 3 aryl substituted oxatriazoles; Nitric oxide; Proliferation; Vascular smooth muscle cell

Indexed keywords

3 (3 CHLORO 2 METHYLPHENYL) 5 (2 PROPYNYLAMINOCARBONYLIMINO) 1,2,3,4 OXATRIAZOLE; 3 (3,4 DICHLOROPHENYL) 1,2,3,4 OXATRIAZOLE 5 IMINE; AMPHOLYTE; ANTIMITOTIC AGENT; CYCLIC GMP; DNA; GUANYLATE CYCLASE INHIBITOR; LINSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL DIVISION; CELLS, CULTURED; CYCLIC GMP; DNA; MALE; MOLSIDOMINE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE DONORS; NITRITES; PENICILLAMINE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRIAZOLES; UREA;

EID: 0031668492     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702076     Document Type: Article

References (35)

1. ALANKO, J., SIEVI, E., LÄHTEENMÄKI, T.A., MUCHA, I., RIUTTA, A. & VAPAATALO, H. (1995). Effects of NO-donors, SIN-1 and GEA 3175, on prostacyclin and cGMP synthesis in cultured rat endothelial cells. Agents Actions, 45, 195-199.
2. 2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. Biochem. J., 288, 527-532.
3. AXELSSON, K.L., BORNEFELDT, K.E., NORLANDER, B. & WIKBERG, J.E.S. (1988). Attomole sensitive radioimmunoassay for cyclic GMP. Sec. Mess. Phosphoprot., 12, 145-154.
4. BUSSE, R. & MÜLSCH, A. (1990). Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett., 275, 87-90.
5. CORELL, T., PEDERSEN, S.B., LISSAU, B., MOILANEN, E., METSÄ-KETELÄ, T., KANKAANRANTA, H., VUORINEN, P., VAPAATALO, H., RYDELL, E., ANDERSSON, R., MARCINKIEWICZ, E., KORBUT, R. & GRYGLEWSKI, R.J. (1994). Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol. J. Pharmacol., 46, 553-566.
6. CORNWELL, T.L., ARNOLD, E., BOERTH, N.J. & LINCOLN, T.M. (1994a). Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol., 267, C1405-C1413.
7. CORNWELL, T.L., SOFF, G.A., TRAYNOR, A.E. & LINCOLN, T.M. (1994b). Regulation of the expression of cyclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells. J. Vasc. Res., 31, 330-337.
8. DUBEY, R.K. (1993). Vasodilator-derived nitric oxide inhibits fetal calf serum-and angiotensin-II-induced growth of renal arteriolar smooth muscle cells. J. Pharmacol. Exp. Ther., 269, 402-408.
9. DUBEY, R.K. & OVERBECK, H.W. (1994). Culture of rat mesenteric arteriolar smooth muscle cells: effects of platelet-derived growth factor, angiotensin and nitric oxide on growth. Cell Tissue Res., 275, 133-141.
10. GARG, U.C. & HASSID, A. (1989). Nitric oxide-generating vasodilatators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest., 83, 1774-1777.
11. GARG, U.C. & HASSID, A. (1993). Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells. Eur. J. Pharmacol., 237, 243-249.
12. GARTHWAITE, J., SOUTHAM, E., BOULTON, C.L., NIELSEN, E.B., SCHMIDT, K. & MAYER, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol., 48, 184-188.
13. GROSS, S.S. & LEVI, R. (1992). Tetrahydrobiopterin synthesis: an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem., 267, 25722-25729.
14. IOANNIDIS, I. & DE GROOT, H. (1993). Cytotoxicity of nitric oxide in Fu5 rat hepatoma cells: evidence for co-operative action with hydrogen peroxide. Biochem. J., 296, 341-345.
15. KANKAANRANTA, H., RYDELL, E , PETERSSON, A.-S., HOLM, P., MOILANEN, E., CORELL, T., KARUP, G., VUORINEN, P., PEDERSEN, S.B., WENNMALM, Å. & METSÄ-KETELÄ, T. (1996). Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br. J. Pharmacol., 117, 401-406.
16. KARIYA, K., KAWAHARA. Y., ARAKI, S., FUKUZAKI, H. & TAKAI, Y. (1989). Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis, 80, 143-147.
17. KARUP, G., PREIKSCHAT, H., WILHELMSEN, E.S., PEDERSEN, S.B., MARCINKIEWICZ, E. CIESLIK, K., & GRYGLEWSKI, R.J. (1994). Mesoionic oxatriazole derivatives a new group of NO-donors. Pal. J. Pharmacol., 46, 541-552.
18. KOIDE, M., KAWAHARA, Y., TSUDA, T. & YOKOYAMA, M. (1993). Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett., 318, 213-217.
19. KWON, N.S., STUEHR, D.J. & NATHAN, C.K. (1991). Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med., 174, 761-767.
20. LEE, R.M.K.W., OWENS, G.K., SCOTT-BURDEN, T., HEAD, R.J., MULVANY, M.J. & SCHIFFRIN, E.L. (1995). Pathophysiology of smooth muscle in hypertension. Can. J. Physiol. Pharmacol., 73, 574-584.
21. LOWRY, O.H., ROSENBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Kolin phenol reagent. J. Biol. Chem., 193, 265-275.
22. MALINSKI, T. KAPTURCZAK, M., DAYHARSH, J. & BOHR, D. (1993). Nitric oxide synthase activity in genetic hypertension. Biochem. Biophys. Res. Commun., 194, 654-658.
23. MCGUIRE, P.G., WALKER-CAPRIOGLIO, H.M., LITTLE, S.A. & MCGUFFEE, L.J. (1993). Isolation and culture of rat superior mesenteric artery smooth muscle cells. In Vitro Cell. Dev. Biol., 29, 135-139.
24. MOILANEN, K., VUORINEN, P., KANKAANRANTA, H., METSÄ-KETELÄ, T. & VAPAATALO, H. (1993). Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions, Br. J. Pharmacol., 109, 852-858.
25. MOORADIAN, D.L., HUTSELL, T.C. & KEEFER, L.K. (1995). Nitric oxide (NO) donor molecules: effect of NO release rule on vascular smooth muscle cell proliferation in vitro. J. Cardiovasc. Pharmacol., 25, 674-678.
26. MORO, M.A., RUSSEL, R.J., CELLEK, S., LIZASOAIN, I., SU, Y., DARLEY-USMAR, V.M., RADOMSKI, M.W. & MONCADA, S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U.S.A., 93, 1480-1485.
27. NILSSON, J., SJÖLUND, M., PALMBERG, L., THYBERG, J. & HELDIN, C.H. (1985) Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. Proc. Natl. Acad. Sci. U.S.A., 82, 4418-4422.
28. NURMINEN, M.-L. & VAPAATALO, H. (1996). Effect of intracerebroventriculur and intravenous administration of nitric oxide donors on blood pressure and heart rate in anaesthetized rats. Br. J. Pharmacol., 119, 1422-1426.
29. RIZVI, M.A. & MYERS, P.R. (1997). Nitric oxide modulates basal and endothelin-induced coronary artery vascular smooth muscle cell proliferation and collagen levels. J. Mol. Cell. Cardiol., 29, 1779-1789.
30. ROSS, R.J. (1971). The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fiber. J. Cell. Biol., 50, 172-182.
31. RUBANYI, G.M. & VANHOUTTE, P.M. (1986). Superoxide unions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol., 250, H822-H827.
32. SCHMIDT, H.H.H.W., WARNER, T.D., NAKANE, M., FÖRSTERMANN, U. & MURAD, F. (1992). Regulation and subcellular location of nitrogen oxide synthase in RAW264.7 macrophages. Mol. Pharmacol., 41, 615-624.
33. SOUTHGATE, K. & NEWBY, A.C. (1990). Serum-induced proliferation of rabbit aortic smooth muscle cells from contractile state is inhibited by 8-Br-cAMP but not 8-cGMP. Atherosclerosis, 82, 113-123.
34. VILPO, J.A., VILPO, L.M., VUORINEN, P., MOILANEN, E. & METSÄ-KETELÄ, T. (1994). Cytotoxicity of mesoionic oxatriazoles: a novel series of nitric oxide donors. In Nitric Oxide. Enzymology and Biochemistry, ed. Moncada, S., Feelisch, M., Busse, R. & Higgs, E.A., vol. IV. pp. 286-291.
35. VILPO, J.A., VILPO, L.M., VUORINEN, P., MOILANEN, E. & METSÄ-KETELÄ, T. (1997). Mode of cytostatic action of mesoionic oxatriazole nitric oxide donors in proliferating human hematopoietic cells. Anti-Cancer Drug Design, 12, 75-89.